Bad - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Products
Bad - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
Bad - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Bad - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
BAD - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
Rabbit anti-BAD (Phospho-Ser136) polyclonal antibody (Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Modifications | Phospho-specific |
Bad Rabbit monoclonal Antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Bad Rabbit monoclonal Antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Bad Rabbit polyclonal Antibody
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
Rabbit Polyclonal Anti-BAD Antibody
| Applications | IHC |
| Reactivities | Human |
Bad Rabbit polyclonal Antibody
| Applications | ELISA, ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Modifications | Unmodified |
热销推荐
Rabbit Polyclonal Anti-BAD Antibody
| Applications | IHC |
| Reactivities | Human |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Reporters
Conjugates
Modifications
Clonalities
Mutants
Assay Types
Families
Pathways
- Acute myeloid leukemia (41)
- Alzheimer's disease (41)
- Amyotrophic lateral sclerosis (ALS) (41)
- Apoptosis (41)
- Chronic myeloid leukemia (41)
- Colorectal cancer (41)
- Endometrial cancer (41)
- ErbB signaling pathway (41)
- Focal adhesion (41)
- Insulin signaling pathway (41)
- Melanoma (41)
- Neurotrophin signaling pathway (41)
- Non-small cell lung cancer (41)
- Pancreatic cancer (41)
- Pathways in cancer (41)
- Prostate cancer (41)
- VEGF signaling pathway (41)
